Cancer Control Program

Student summary

Why This Research Matters

The Cancer Control Program (CCP) at the Abramson Cancer Center, as detailed in its NIH RePORTER record with identifier pmid:4P30CA016520-50 and associated source URL https://reporter.nih.gov/project-details/11469228, represents a significant collaborative research initiative focused on cancer control. This program is one of two Population Science Research Programs within the ACC and operates as a highly transdisciplinary effort involving 39 members from diverse academic backgrounds including Perelman School of Medicine, School of Nursing, Wharton School of Business, and Annenberg School for Communication. The CCP's overarching mission is to identify genetic, behavioral, and health care determinants influencing cancer susceptibility and outcomes across varied populations, while simultaneously developing, evaluating, and implementing interventions aimed at reducing risk factors and improving overall cancer-related health outcomes.

The research conducted by the CCP is organized into four interconnected aims: Cancer Genomics and Risk; Communication and Health Behavior; Cancer Survivorship; and Health Care Outcomes. Within these areas, members have made notable contributions during the current funding period (which appears to be around 2026 based on publication date). For instance, in Cancer Genomics and Risk, researchers established clinical management protocols for individuals with moderate penetrance risk genes for breast and colorectal cancer, identified new genetic loci associated with susceptibility to testicular germ cell tumors, and demonstrated the comparable efficacy of telehealth-delivered genetic counseling. In Communication and Health Behavior research, innovative studies were conducted on using incentives to improve early detection rates and novel transdisciplinary work in diet, obesity, and their relationship to cancer risk was undertaken. The Cancer Survivorship aim saw members establish clinical paradigms for patient-centered care plans for survivors and uncover important complexities related to end-of-life care. Lastly, the Health Care Outcomes research arm innovated methods using electronic health records (EHRs) to improve health behaviors and conducted pragmatic trials aimed at developing new models of high-quality cancer care.

The CCP is not only a hub for cutting-edge research but also plays a crucial role in training the next generation of cancer control researchers. During the current funding period, 17 new members were recruited into areas such as epidemiology, genomics, biostatistics, informatics, nutrition, and the microbiome. This influx of talent underscores its commitment to advancing population science.

In terms of productivity, CCP has produced a substantial body of high-impact work. Over the current funding period, there have been 640 cancer-related publications (13% intra-programmatic, 35% inter-programmatic, and 76% multi-institutional). The program also boasts significant research funding: members hold 30 R01-equivalent grants totaling $14.5 million in direct annual cancer-related research funding, with $11.6 million coming from peer-reviewed sources and $3.8 million specifically from the National Cancer Institute (NCI).

The CCP actively enrolls subjects into various trials; during the current period, members enrolled 10,768 individuals onto interventional trials (including 819 onto treatment trials) and 2,923 subjects onto non-interventional trials. This extensive trial activity highlights its commitment to evidence-based practice.

The program collaborates closely with other research initiatives, notably the Tobacco and Environmental Carcinogenesis Program, to create a robust population science presence at the ACC. The CCP's work is characterized by its interdisciplinary nature, combining insights from medicine, nursing, business, communication, and public health to address complex cancer issues comprehensively.

For students of nursing or related fields, understanding the scope and achievements of such programs like the Cancer Control Program is vital. It illustrates how research can directly translate into improved patient care strategies, better risk assessment tools, more effective survivorship support systems, and innovative approaches to managing health outcomes through technology like EHRs. The CCP's focus on training new researchers also emphasizes the importance of ongoing education and professional development in advancing cancer control efforts.

When appraising this record from NIH RePORTER, it is important to note that while it provides a wealth of information about the program's activities, publications, funding, and collaborations, it does not contain specific details about individual study designs (e.g., randomized controlled trials) or detailed statistical outcomes beyond enrollment numbers. The abstract primarily serves as an overview of project achievements rather than detailing specific research findings from primary studies conducted by its members. Therefore, students should approach this record as a high-level summary of programmatic activity and impact.

The source metadata indicates that the information comes directly from NIH RePORTER (sourceName:

Faculty notes

Educational Relevance

Cancer Control Program can be used for source-grounded discussion. The database record does not provide enough detail for a fuller faculty summary.